NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

"MHRA will (in my opinion) give DCVax-L it's licence and NICE will agree terms with NWBio which will likely be cheaper than the current SOC that Big Pharma charge."

This statement is ridiculous and also impossible. If DCVax ever got an approval, it would be give IN ADDITION TO SOC as an adjuvant, not as a replacement. Therefore making the cost a lot higher to the NHS. You really need to speak to a professional financial advisor before you keep losing money.